Isotretinoin‐associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19477 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Clio Dessinioti und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Dermatology, Venereology, Acne Vulgaris. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Acne fulminans (AF) is a rare severe acne entity. Although occasionally reported, it is unclear whether AF development is associated with oral isotretinoin treatment.
Objectives
To investigate the occurrence of isotretinoin‐associated AF, clinical characteristics and prognosis at follow‐up.
Methods
An international, multicentre, retrospective study was performed in eight hospitals following the call of the EADV Task Force on Acne, Rosacea and Hidradenitis Suppurativa (ARHS). Characteristics of patients treated with isotretinoin before the development of AF (isotretinoin‐associated acne fulminans, IAF) were compared with non‐IAF (NAF).
Results
Forty‐nine patients diagnosed with AF from 2008 to 2022 were included (mean age 16.4 years, SD 2.9, 77.6% male). Αrthralgias/arthritis occurred in 11 patients (22.9%). AF occurred without any previous acne treatment in 26.5% of the patients. Overall, 28 patients (57.1%) developed AF after oral isotretinoin intake (IAF group), while the remaining 21 patients (42.9%) developed AF without previous oral isotretinoin administration (NAF group). IAF occurred after a median duration of isotretinoin treatment of 45 days (IQR: 30, 90). Patients with IAF were more frequently male compared to patients with NAF (89.3% vs. 61.9%, respectively, p = 0.023). There were no differences in patients with IAF versus NAF in patient age, the duration of pre‐existing acne, a family history of AF, the distribution of AF lesions or the presence of systemic symptoms or arthralgias. Regarding the management of AF, patients with IAF were treated more frequently with prednisolone (96.2%) compared to those with NAF (70%; p = 0.033) and less frequently with isotretinoin (32.1%) compared to NAF (85.7%; p < 0.001). At a median follow‐up of 2.2 years, 76.4% of patients were free of AF and scarring was present in all patients.
Conclusions
No specific clinical or demographic characteristics of IAF compared with NAF could be detected, a fact that does not support IAF as a district clinical entity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece.
- Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, Nantes, France.
- Department of Medical Sciences, Section of Dermatology, University of Ferrara, Ferrara, Italy.
- Department of Dermatology and Venereology, Koç University School of Medicine, İstanbul, Turkey.
- Department of Physiotherapy and Medical Emergency, Faculty of Health Sciences, Pomeranian University, Slupsk, Poland.
- Department of Dermatology, Provincial Specialist Hospital, Slupsk, Poland.
ORCID-Profile: Clio Dessinioti, Brigitte Dréno, Vincenzo Bettoli, Piotr Brzezinski, Åke Svensson
Zitieren
APA
Dessinioti, C., Dréno, B., Bettoli, V., Vural, S., Brzezinski, P., Nassif, A., Svensson, Å., & Zouboulis, C. C. (2024). Isotretinoin‐associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19477
Vancouver
Dessinioti C, Dréno B, Bettoli V, Vural S, Brzezinski P, Nassif A, et al. Isotretinoin‐associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19477
BibTeX
@article{Dessinioti2024,
author = {Dessinioti, Clio and Dréno, Brigitte and Bettoli, Vincenzo and Vural, Secil and Brzezinski, Piotr and Nassif, Aude and Svensson, Åke and Zouboulis, Christos C},
title = {Isotretinoin‐associated acne fulminans: A multicentre, retrospective study of the European Academy of Dermatology and Venereology Task Force on Acne, Rosacea and Hidradenitis Suppurativa},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19477}
}
EUVIMED